Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of Cancer Ablation and Qilisheng for Unresectable Liver Cancer
NCT03239158Phase 3Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Sep 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Life information rehabilitation therapy in liver cancer, sponsored by Fuda Cancer Hospital. Started Sep 2017; status: completed.
02
Drugs
Life information rehabilitation therapy
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT03239158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03239158.